Provided by Tiger Fintech (Singapore) Pte. Ltd.

OPKO Health

1.41
-0.0500-3.42%
Post-market: 1.470.0600+4.26%19:51 EDT
Volume:3.30M
Turnover:4.69M
Market Cap:946.89M
PE:-18.39
High:1.46
Open:1.44
Low:1.40
Close:1.46
Loading ...

OPKO Health Initiated at Neutral by JP Morgan

Dow Jones
·
Yesterday

Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround

Zacks
·
22 Apr

NextPlat Says Tariffs Will Keep New Line of U.S. Goods From Going to China

Dow Jones
·
12 Apr

BRIEF-NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program

Reuters
·
12 Apr

NextPlat Corp: Intends to Continue Selling OPKO Health Europe Products in China

THOMSON REUTERS
·
12 Apr

NextPlat Corp: Current U.S./China Tariff Condition to Have Material Impact on Expected Sales of U.S. Products Into China

THOMSON REUTERS
·
12 Apr

OPKO Health Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
08 Apr

OPKO Health’s Strategic Buyback and Innovative Partnership Drive Yi Chen’s Buy Rating

TIPRANKS
·
07 Apr

OPKO Health Boosts Stock Buyback Program by $100 Million

MT Newswires Live
·
04 Apr

Opko Health board authorizes $100M increase to existing share repurchase program

TIPRANKS
·
04 Apr

BRIEF-Opko Health Announces $100 Million Increase To Its Existing Share Repurchase Program

Reuters
·
04 Apr

OPKO Health Announces $100 Million Increase to Its Existing Share Repurchase Program

THOMSON REUTERS
·
04 Apr

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

GlobeNewswire
·
04 Apr

Piper Sandler Remains a Buy on Opko Health (OPK)

TIPRANKS
·
02 Apr

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

Zacks
·
28 Mar

OPKO Health Insider Ups Holding During Year

Simply Wall St.
·
27 Mar

Chairman & CEO of OPKO Health Phillip Frost Buys More Stock

Simply Wall St.
·
20 Mar

OPKO Health Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
19 Mar

Opko Health, Entera Bio to Collaborate on Tablet for Obesity, Metabolic and Fibrotic Disorders

Dow Jones
·
17 Mar

OPKO, Entera to Co-Develop Oral GLP-1/Glucagon Therapy for Obesity

MT Newswires Live
·
17 Mar